Welcome to
Allurion’s Blog

January 24, 2018

A balloon for obesity: an option between medication and surgery?

The Elipse Balloon was recently covered by Melissa Healy of the LA Times in an article entitled A balloon for obesity: an option between medication and surgery? Here is an excerpt: For many struggling with obesity, taking one of the newly approved prescription medications for weight loss (marketed as Qsymia, Belviq and Contrave) feels like climbing a mountain with a walking cane — it’s a little help, but not enough. And bariatric surgery — a permanent replumbing of the intestinal tract that is expensive and carries the risks of major surgery — feels like a bit too much help. Could a water balloon…

January 24, 2018

Data Presented on New Gastric Balloons for Weight Loss

Louise Gagnon recently interviewed Allurion’s Chief Scientific Officer Shantanu Gaur for her story in General Surgery News on the Elipse Balloon. The article highlights Allurion’s presentation at this year’s International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) World Congress and underscores the key differences between the Elipse Balloon and all other gastric balloons in development. Here’s an excerpt: In an interview with General Surgery News, Dr. Gaur pointed out that the Elipse has distinct advantages over other intragastric balloons. “The difference with our device, compared to other intragastric balloons, is that it does not require endoscopy or anesthesia,” Dr. Gaur said. Click…

January 24, 2018

Patient Preference for Weight Loss Devices

The US Food and Drug Administration (FDA) recently published an article in Surgical Endoscopy that reports results of a survey conducted on patient preference for weight loss devices. The survey quantifies the risk-benefit analysis many patients conduct before deciding on a weight loss therapy. This research is part of a laudable, ongoing effort at FDA to incorporate patient preference in regulatory decision-making. Moreover, the research provides very useful quantitative data to support FDA’s risk-benefit paradigm for evaluating new weight loss devices. In fact, this approach was instrumental in the recent approval of the Enteromedics VBLOC device. While the device failed…

January 24, 2018

Allurion co-founders featured in LeadDoc

Allurion Technologies co-founders Shantanu Gaur and Samuel Levy were featured in the latest edition of Lead Doc – the online journal for emerging physician leaders. Click here to read their story!

January 24, 2018

Elipse Gastric Balloon Featured in WebMD

Allurion’s Elipse was recently featured in WebMD’s Future of Health series in an article entitled “The Next Generation of Weight Loss.” Click here to see the story!

January 24, 2018

Allurion Technologies: A Treatment for Obesity That’s Easy to Swallow

Allurion Technologies and the Elipse Balloon were featured in the March issue of Medtech Strategist in an article entitled “Allurion Technologies: A Treatment for Obesity That’s Easy to Swallow”. Thank you to Mary Stuart for a very thoughtful profile of our company and device. Click here to access the article!

August 22, 2017

Allurion’s Shantanu Gaur on Jim Cramer’s Mad Money

Allurion Technologies founder discusses his company’s non-invasive ‘balloon’ pill that helps treat obesity from CNBC.

April 14, 2016

Why have healthcare companies and physicians failed to solve the obesity epidemic?

In a recent guest post on MedCity News, Dr. Shantanu Gaur asks why healthcare companies and physicians have failed to solve the obesity epidemic. The answer has much more to do with how we treat the consumer than how we think about technology. Check out the article here!

February 23, 2016

Three Things The Tech Industry Has Right And The Medical Industry Has Wrong

Dr. Shantanu Gaur recently authored a guest post on TechCrunch on what the medtech industry can learn from the tech industry. Namely, 1) be open with data; 2) create an experience, not just a product; and 3) treat users as participants, not just purchasers. Check out the article here!

May 27, 2015

Allurion Technologies: A Treatment for Obesity That’s Easy to Swallow

Allurion Technologies and the Elipse Balloon were featured in the March issue of Medtech Strategist in an article entitled “Allurion Technologies: A Treatment for Obesity That’s Easy to Swallow”. Thank you to Mary Stuart for a very thoughtful profile of our company and device.